Debulking Surgery
Feasibility of Upfront Debulking Surgery versus Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery for Advanced Ovarian Cancer
... Radical debulking surgery is considered the cornerstone in the management of advanced ovarian cancer pointing to complete tumor resolu- ...optimal debulking cannot be achieved, these patients gain ...
11
The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study
... Two cases of relapse after biopsy (13.3%) were noted during the follow-up period. Serum IgG4, sIL-2R and IgE levels were not significantly different between patients with and without recurrence (table 2). Among the ...
5
<p>A radiologic-laparoscopic model to predict suboptimal (or complete and optimal) debulking surgery in advanced ovarian cancer: a pilot study</p>
... after surgery remains the most important prognostic factor in AOC, and the decision between primary debulking surgery and interval debulking surgery after neoadjuvant chemotherapy ...
10
Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer
... of chemotherapy and consequently they will worsen the prognosis [4-6]. For about two decades the neoadjuvant chemotherapy has been successfully used in gynecologic oncology, in order to reduce the tumour mass and enable ...
12
Predictive value of changes in the serum CA 125 levels in patients undergoing interval debulking surgery after neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
... interval debulking surgery. Standard debulking procedure includes total abdominal hysterectomy, bilateral salpingo oopherectomy, total omentectomy, bilateral lymph node dissection and removal of ...
5
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG G1402)
... A third limitation is the potential for selection bias, such as similar tumor sizes and number of relapse sites. This bias might influence the presence of residual tumor after debulking surgery and/or the ...
7
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
... Primary debulking surgery (PDS) followed by platinum-based chemotherapy has long been consid- ered the only standard treatment for advanced epithe- lial ovarian cancer (EOC) ...delayed surgery ...
7
The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer
... cytoreductive surgery; advanced-stage epithe- lial ovarian, fallopian tube, and peritoneal cancer (FIGO stage III or IV); and FDG PET/CT performed less than 90 days before ...before surgery, patients who ...
8
Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer
... primary surgery included tumor deposits covering a greater part of the parietal peritoneum and enteric sur- face, combined infiltration of the periaortic space and mesentery, and infiltration of the hepatic ...
6
Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report
... by surgery following their conversion to resectable tumors by imatinib therapy [13, ...underwent surgery for residual lesions after having responded to imatinib therapy was higher than that in patients with ...
7
Debulking surgery for venous hemangioma arising from the epicardium: report of a case
... Most cardiac hemangiomas are asymptomatic and found incidentally, though they may present with dys- pnea, palpitation, arrhythmia, murmur, pericardial effusion, or thromboembolic events; symptoms usually depend on tumor ...
5
Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage III C and IV epithelial ovarian cancer
... A total of 38,792 patients diagnosed between January 1, 1992 and December 31, 2009 with invasive ovarian cancer (SEER primary site code C569) as their only tumor or first primary tumor with the second tumor at least 2 ...
10
Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report
... reported in only two out of eight immature teratoma pa- tients with greater than 15-year remission in both cases (186 and 202 months respectively). Rezk Y et al. reported a case similar as ours [18] with a grade 3 ...
6
Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
... with debulking surgery or chemotherapy be- tween January 1995 and December 2016; and who had complete clinical data in the medical record ...contraindicated surgery or platinum-based chemotherapy; ...
8
Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis
... sensitivity to chemotherapy, are quite different from one another [3]. Serous carcinoma (SC) is the most common subtype of epithelial ovarian carcinoma and also known for its sensitivity to platinum-based chemotherapy. ...
9
<p>Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience</p>
... Although NACT decreases treatment-related morbidity and mortality, many types of complicated surgical procedures are still involved in IDS. Researchers from the Mayo Clinic showed that 14.9% of ovarian cancer patients ...
10
Outcomes of Non High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: Single Institution Experience
... NAC followed by IDS has been widely used for advanced- stage ovarian cancer, particularly for patients with an unre- sectable high tumor burden, old age, and a poor performance status. However, characteristics of the ...
7
Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature
... interval debulking surgery, OV ovary, LN lymph node, CNS central nervous system, meta metastasis, RT radiation, Chem chemotherapy, CDDP cisplatin, CPA cyclophosphamide, CBDCA carboplatin, PTX paclitaxel, ...
8
Download Download PDF
... mary debulking surgery and neoadjuvant chemo- ...of surgery, intraoperative blood loss, intraopera- tive organs injury, length of stay in intensive care unit (ICU), and also the total hospitalization ...
5
How to improve the optimal cytoreductive surgery in advanced ovarian carcinoma
... in debulking surgery and adjuvant chemotherapy ...is surgery. A debulking procedure may not be enough: the goal is to achieve a complete ...cancer surgery and the abdominal procedures ...
10